Abstract -This paper investigates the depth of anaesthesia (DoA) control system using robust deadbeat technique. We propose to apply deadbeat control technique and develop a robust controller. The proposed robust control system with a deadbeat controller is evaluated in simulation. The performance is compared with that of a traditional control system with a PID controller and a control system with an internal model (IMC) controller. The results show that the proposed scheme has about 15% less overshoot, shorter settling time (about 1.5 minutes shorter) and more robust to disturbances caused by parameter changes. In addition, the proposed method is easy to design and impalement.
I. INTRODUCTION
More recently, considerable efforts have been made to identify and control systems with uncertainty and nonlinearity in medical related control system. Dwayne (1997) developed a closed-loop PID controller to control the depth of anesthesia [1] . Sakai et al. (2000) employed a closed-loop PID control system for propofol administration using BIS (Bispectral Index) as the controlled variable. Both of them concluded that their systems provided intra-operative hemodynamic stability and a prompt recovery from the sedative-hypnotic effects of propofol [2] . Absalom et al. (2002) developed a similar closed-loop PID controller using BIS as the controlled variable, and a propofol targeting central plasma concentration-controlled infusion system as the control actuator [3] . The authors concluded that further studies were required to determine if control performance could be improved by changing the proportional gains of the PID controller or by using an effect-site-targeted propofol controlled infusion system. Later, they modified their control algorithm to a target-controlled infusion (TCI) system which regulated effect-site concentration, and proved it to be more efficient. However, the PID controller still faced some stability problems [4] .
This study applies the deadbeat robust control technique to the depth of anaesthesia. First, a DoA model is build up based on our literature review. This model is a single-input single-output (SISO) system with nonlinear component. Then, a PID-based robust deadbeat control scheme is applied to the First we consider the drug modeling approach and how the administered drug distributes within the body. This step leads to a pharmacokinetic model (PK) which can be used to predict the blood plasma concentration of the drug [6] . The second step is the mathematical expression relate to concentration to the drug effect itself. This expression is referred to as pharmacodynamic model (PD) [7] .
A. Pharmacokinetics
Pharmacokinetics is the study of the absorption, distribution, metabolism and elimination of drugs by the body as shown in Fig. 1 . The pharmacokinetic model of a drug is a mathematical term relating to the drug blood plasma concentration Cp (5) to the administered dose u(s). The aim of this section is thus to define the transfer function of PK(s): 
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The PK can be expressed as a time course of the concentration of any given drug within the plasma and other tissues of the human body. Throughout the absorption phase following an intravenous bolus administration, the anaesthetic (propofol) mixes quickly within the central blood pool, resulting in a plasma peak concentration [8] . There is a delay elapses between the actual injection of the anaesthetic (propofol) and its mixing within the blood pool. Systemic circulation then distributes the anaesthetic to a variety of tissues within the body [6] . The time course of the concentration for most drugs, within the blood plasma after the intravenous administration and uptake can be fitted to resemble a decaying function, with two distinct modes corresponding to the distribution and elimination phase respectively. This behavior can be expressed mathematically as:
where Cp (t) is the drug plasma concentration expressed in microgram per milliliter (p ropofol), A is the rate constant of the distribution phase, B is the rate constant of the elimination phase. In many cases, a tri-exponential model will capture the kinetic of the drug much better [6] .
(3)
where Z and C to describe the fast dynamics corresponding to the distribution phase.
A main advantage of exponential models is that they can be simply derived using graphical means. The identification can be carried out directly by using either bolus data or analysing the decaying blood plasma characteristic, or by using infusion data and analysing how the plasma concentration increases over time [6] .
In terms of control and system engineering, the exponential model in (3) can be directly expressed as:
The total amount of the anaesthetic delivered into compartment one (C1) is eliminated according to the rate constant klO. The anaesthetic is distributed in the other two 108 compartments (C 2, C3 ) at a rate of k12 and k13 . The concentration of C1 decreases quickly while the concentrations C2 ,C3 increase. Once the concentrations in the compartment one and any of the peripheral compartments (C2, C3) attain and reach equilibrium, the distributive process setback and the anaesthetic stored in the peripheral compartment returns back to the central compartment at the rate of k21 or k31. Because the blood of the compartment one acts as a transporter for the anaesthetic, that is mean there is no direct exchange between the two peripheral compartments. In other words, only the anaesthetic presents in the compartment one can be eliminated [7] .
The mathematical expressions in a state space representation can be obtained by writing the mass balance equations in (5):
where V I is the volume of compartment one. Also, by definition, the plasma blood concentration equals the drug concentration of the compartment one, i.e., Cp (t) = C1 (t).
In order to simplify the PK(s) model as a SISO transfer function using both the exponential and compartmental parameters as in (6) [9] :
Pharmacodynamics (PD) is the study of the effects of drugs and the relationship between drug concentration and effect. The function of the PD model is to mathematically express the observed effect of a drug as a low-pass filter is used to relate the propofol plasma concentration as shown in Fig. 2 [6]:
where PO(s) is the pharmacodynamic model and E(s) is the drug effect.
The effect-site concentration is related to DoA as (Hill equation) [10] .
The mathematical express of the effect site drug concentration Ce(s) as a function of the plasma concentration C p (s) as in equation (9): 3 shows the basic structure of the robust deadbeat control system, and Table I is the deadbeat controller coefficients and response times. This technique is initially works only for lower-order plants [11] . If a higher-order plant systems considered, then there is a need for higher gain, therefore this design with a proper and accurate high gain result in systems that are intensive to plant parameters variation and uncertainties of up to SO% [S] . Changes in patient's PK and PD parameters (k I o, k12, k13, ........ ECso, Y and keo) form 10% to 20%, 30%, 40% up to SO% the robust deadbeat controller is still able to tolerate these parameter changing.
The deadbeat controller design and derivation method utilizes the following procedures. Firstly using a PID controller as Ge(s), and then adding a cascade gain K before the PID controller. Add a state variable feedback gain Ka, that will make the system over specified by at least one variable. Determine the number of poles for GeG(s), where n p equals the number of poles in GeG(s).Refer to Fig. 3 the feedback H(s) it depends on the number of poles in GeG(s),and the following steps are involved with this method:
2) H(s) = 1 + KbS for np = 3 or4.
3) H(s) = 1 + KbS + KcS 2 for np = 5.
And then select gains, using the coefficients from Table 1 , to achieve the deadbeat response with the following requirements:
4) Set K = 1. 6) The characteristic equation of the closed loop transfer equation will equal to:
The root of H(s) must be real and negative. The design procedure of a PID-based robust deadbeat control, taking fourth-order F,(s) and fifth-order F2(s) systems as examples (10) and For equations (10) and (11), the coefficients a, p, y and 0 are selected from Table 1 . Taking the fourth-order system first as an example and then using the same procedure with fifth order system with a desired settling time 0.95 s, from To apply the deadbeat technique to DoA model, first comparing the characteristic equation in equation (12), with the characteristic equations different patients.
A. DoA Controller Design
The block diagram of the DoA designed system is depicted in Fig. 4 . The desired settling time for DoA is 6 minutes, then wn can be found as:
T; 4.81
Therefore the characteristic equation now can be written as:
S4 + 0.03674s3 + 9.76115 X 1O-4s2 + 1.304 x 1O-5s + 7.7779 X 10-8
Let K equal to 1, and then by comparing the characteristic equation to fmd the variables as: Kc = 1 X 10-4; Kb = 1 X 10-7 Increase K until the response becomes deadbeat and settling time becomes approximately to the desired value.
IV. SIMULATION AND RESULTS
The proposed control schemes were implemented and evaluated using Simulink and Matlab control toolbox to thoroughly investigate the system performance. , -----I Me Time, t (min) 
V. CONCLUSIONS
This study investigates a robust deadbeat control technique in DoA control. This technique was originally designed to suppress system parameters uncertainties. We applied this technique to accommodate the inter-patient differences for DoA control
The proposed method is implemented and evaluated in simulation using realistic data. The results are compared with the results obtained using two other methods. The comparisons show that the proposed robust deadbeat control scheme performs better both in overshoot/undershoot and settling time. The system settling time has been reduced to 1.5 minutes and the over and undershoot also has been shorted about 15%.
